Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07476248

The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
84 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The study aims to examine the relationship between the non-high-density lipoprotein cholesterol-to-high-density lipoprotein cholesterol ratio (NHHR) and CKD in patients with DM.

Detailed description

The study will include adult participants recruited from outpatient clinics and inpatient departments. Participants will be classified into the following groups: 1. Diabetes Mellitus without Diabetic Nephropathy (DM group) : Patients with diabetes mellitus who have no evidence of diabetic nephropathy will be defined by a normal urinary albumin-to-creatinine ratio (UACR) and preserved renal function. 2. Diabetic Nephropathy group (DN group) : Patients with diabetes mellitus and diabetic nephropathy will be defined by the presence of elevated UACR and/or impaired renal function as assessed by estimated glomerular filtration rate (eGFR). Subgroup Analysis : Within the diabetic nephropathy group, further subgroup analyses will be performed to assess differences in NHHR according to: Type of diabetes (Type 1 vs. Type 2 diabetes mellitus) Stages of chronic kidney disease (CKD) are classified based on KDIGO definitions of CKD based on estimated GFR and albuminuria. Type of the study: Comparative cross-sectional study

Conditions

Timeline

Start date
2026-10-01
Primary completion
2027-10-01
Completion
2027-12-01
First posted
2026-03-17
Last updated
2026-03-17

Source: ClinicalTrials.gov record NCT07476248. Inclusion in this directory is not an endorsement.